Michal Aharonowiz,Ofira Einstein,Benjamin Reubinoff,Tamir Ben-Hur
申请号：
US15826235
公开号：
US20180080007A1
申请日:
2017.11.29
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention concerns the use of a population of cells comprising: (a) neural precursor cells committed to an oligodendroglial fate (b) uncommitted neural precursor cells (c) differentiated oligodendrocytes or (d) a combination of any one of (a) to (c) for the treatment of CNS autoimmune diseases, or for the preparation of a pharmaceutical composition for treating CNS autoimmune diseases, the population of cells being derived from human pluripotent stem cells. The invention also provides methods for obtaining such populations of cells, namely, neural precursor cells committed to an oligodendroglial fate as well as differentiated oligodendrocytes which then can be used in the treatment of CNS autoimmune diseases. A preferred autoimmune disease in the context of the present invention is multiple sclerosis where the population of cells is administered to the CNS for local treatment of the disease.
